NFKB1 and in situ carcinoma: Interestingly, expression of IFNα and IFNγ pathway genes was upregulated by treatment with CIS, ETP, or 5FU, but not with DTX, whereas NFκB pathway genes were upregulated by all drugs tested (Supplemental Fig. S4).